Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Investigating whole-brain metabolite abnormalities in the chronic stages of moderate or severe traumatic brain injury 2022
2021 Return to Driving After Moderate-to-Severe Traumatic Brain Injury: A Traumatic Brain Injury Model System Study.  Archives of Physical Medicine and Rehabilitation.  102:1568-1575. 2021
2021 Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome..  Archives of Rehabilitation Research and Clinical Translation.  3:100123. 2021
2021 Driving patterns, confidence, and perception of abilities following moderate to severe traumatic brain injury: a TBI model system study.  Brain Injury.  35:863-870. 2021
2021 Factors Increasing Risk of Suicide after Traumatic Brain Injury: A State-of-the-Science Review of Military and Civilian Studies.  Brain Injury.  35:151-163. 2021
2019 Effects of Statin Treatment on Outcomes after Traumatic Brain Injury.  Journal of Neurotrauma.  36:118-125. 2019
2018 The effect of donepezil on the cognitive ability early in the course of recovery from traumatic brain injury.  Brain Injury.  32:972-979. 2018
2017 Natural history of headache five years after traumatic brain injury.  Journal of Neurotrauma.  34:1558-1564. 2017
2014 Zolpidem and restoration of consciousness..  American Journal of Physical Medicine and Rehabilitation.  93:101-113. 2014
2011 Natural history of headache after traumatic brain injury.  Journal of Neurotrauma.  28:1719-1725. 2011
2010 Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury.  Journal of Head Trauma Rehabilitation.  25:357-361. 2010
2010 Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: A multicenter observational study.  Journal of Trauma and Acute Care Surgery.  68:916-923. 2010
2009 Impact of early administration of sertraline on depressive symptoms in the first year after traumatic brain injury.  Journal of Neurotrauma.  26:1921-1928. 2009
2009 A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke.  Archives of Physical Medicine and Rehabilitation.  90:1453-1461. 2009
2005 A descriptive study of pain and quality of life following Guillain-Barré syndrome: One year later.  Journal of Clinical Psychology in Medical Settings.  12:111-116. 2005
2004 Orally Delivered Baclofen to Control Spastic Hypertonia in Acquired Brain Injury.  Journal of Head Trauma Rehabilitation.  19:101-108. 2004
2003 Cyproheptadine for intrathecal baclofen withdrawal..  Archives of Physical Medicine and Rehabilitation.  84:638-642. 2003
2003 Screening for venous thromboembolism in traumatic brain injury: Limitations of D-dimer assay.  Archives of Physical Medicine and Rehabilitation.  84:285-290. 2003
2003 Letters to the Editor.  Journal of Head Trauma Rehabilitation.  18:5-6. 2003
2002 Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial.  Journal of Head Trauma Rehabilitation.  17:300-313. 2002
2001 Intrathecal baclofen for spastic hypertonia from stroke.  Stroke.  32:2099-2107. 2001

Education And Training

  • Baptist Medical Center - Montclair, Internship
  • UAB Hospital, Residency
  • Doctor of Medicine, University of Alabama at Birmingham 1994
  • Bachelor of Science or Mathematics in Microbiology, University of Alabama 1990

    • Full Name

  • Robert Brunner